Antithrombin gamma
- Generic Name
- Antithrombin gamma
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1311281-25-0
- Unique Ingredient Identifier
- 29Y3UO9LWK
- Background
Antithrombin gamma is under investigation in clinical trial NCT04182373 (KW-3357 Study in Patients With Early Onset Severe Preeclampsia).
- Associated Conditions
- -
- Associated Therapies
- -
KW-3357 Study in Patients With Early Onset Severe Preeclampsia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-12-02
- Last Posted Date
- 2023-11-15
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 181
- Registration Number
- NCT04182373
- Locations
- 🇯🇵
National Center for Child Health and Development, Setagaya, Tokyo, Japan
🇯🇵Aiiku Hospital, Minato, Tokyo, Japan
🇯🇵Okinawa prefectural Chubu Hospital, Uruma, Okinawa, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath